纠结集采制

Dilemma for Group Procurement

2013年7月以来，中国药品生产流通领域充斥着一股肃杀之气。以葛兰索史克为始，多家大型药企在华行贿曝光，让中周现行的药品集中招标采购制度再次受到拷问。以遏制医疗腐败为目标而设立的药品集中招标采购制度，尽管几经改革，仍摆脱不了成为药品购销腐败帮凶的命运，颇含讽刺意味。

A shadow was casted on pharmaceutical industry in China ever since the briberies were exposed in July 2013. Although the corruption was scandalous, one has to wonder whether there is something wrong with the current group procurement of medicine, since him primary aim of group procurement is to eliminate the corruption in the supply chain. However, as the medical behaviors have been twisted, the group procurement actually provides a platform for the corruption and makes it more convenient and obscure.